Results 191 to 200 of about 1,142,441 (317)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Dispersion engineering by rotational symmetry breaking in an optical microcavity. [PDF]

open access: yesLight Sci Appl
Ren JZ   +5 more
europepmc   +1 more source

Insight Engines im Controlling

open access: yesControlling & Management Review, 2020
openaire   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

open access: yesMolecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

A Novel Technique for Quality Control of Microinjection Molding. [PDF]

open access: yesMicromachines (Basel)
Daoud AN   +3 more
europepmc   +1 more source

Engineering Control of Occupational Diseases [PDF]

open access: yesAmerican Journal of Public Health and the Nations Health, 1935
openaire   +2 more sources

Editorial: Evolution mechanism and control method of engineering disasters under complex environment [PDF]

open access: gold
Jianyong Han   +5 more
openalex   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy